Summary Slide.png (107.55 kB)
Cost-Effectiveness of Atezolizumab plus chemotherapy as first-line therapy for metastatic urothelial cancer
media
posted on 2021-05-17, 16:21 authored by Adis Rapid Journals on behalf of:, Shuxia Qin, Lidan Yi, Sini Li, Chongqing Tan, Xiaohui Zeng, Liting Wang, Ye Peng, Xiaomin WanArticle full text
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.
